The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis

scientific article published on August 1990

The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0950-3579(05)80017-2
P698PubMed publication ID2032296

P2093author name stringP Lee
M B Urowitz
P2860cites workAzathioprine in rheumatoid arthritis: a long-term follow-up studyQ33333205
Long-term prospective trial of low-dose methotrexate in rheumatoid arthritisQ33449383
Long-term effects of azathioprine in rheumatoid arthritisQ33625350
Delayed-onset chloroquine retinopathyQ33645172
Ophthalmological safety of chloroquineQ33967103
Effect of Chloroquine on Morphology of Cytoplasmic Granules in Maturing Human Leukocytes—an Ultrastructural Study*Q34089097
STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VI. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE.Q35308463
Pharmaco-epidemiology--drugs, arthritis, and neoplasms: industry contribution to the dataQ36488201
Is chloroquine obsolete in treatment of rheumatic disease?Q39534526
Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritisQ39617414
Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safetyQ39664793
An appraisal of chloroquineQ39990460
Methotrexate guidelines--revisedQ40326046
Chloroquine treatment in rheumatoid arthritis. Correlation of clinical response to plasma protein changes and chloroquine levelsQ40972345
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprineQ41117952
The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritisQ41200879
The use of Amsler grids in early chloroquine retinopathyQ41918246
Dose refinements in long-term therapy of rheumatoid arthritis with antimalarialsQ41921005
Ophthalmologic safety of long-term hydroxychloroquine sulfate treatmentQ41921011
Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapyQ41921017
Hydroxychloroquine. Seven-year experienceQ41923750
Chloroquine retinopathy in patients with rheumatoid arthritisQ41931428
Dosage of Antimalarial Drugs for Children with Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Clinical Study with Determination of Serum Concentrations of Chloroquine and HydroxychloroquineQ41933594
Experimentally Induced Chloroquine Retinopathy in RabbitsQ41940853
Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) TherapyQ41941073
Chloroquine retinopathy. Early detection by retinal threshold testQ41942216
Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy. A study of 741 patients treated with and without chloroquine drugsQ41942635
RETINOPATHY FOLLOWING THE USE OF CHLOROQUINE AND ALLIED SUBSTANCES.Q41943082
THE PATHOLOGY OF CHLOROQUINE RETINOPATHY.Q41943979
Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findingsQ41945009
Impaired Vision after Prolonged Chloroquine TherapyQ41945312
The ocular complications of chloroquine therapyQ41946632
Ocular effects and safety of antimalarial agentsQ41947045
Death Rate and Causes of Death in Patients with Rheumatoid ArthritisQ42139986
Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samplesQ42203139
Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexateQ42210591
Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatmentQ42434922
Increased Mortality Among Persons with Rheumatoid Arthritis, But Where RA Does Not Appear on Death Certificate:Eleven-Year Follow-Up of an Epidemiological StudyQ44204294
Death rate and causes of death in RA patients during a period of five yearsQ44514814
Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatmentQ46242303
Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.Q53793714
Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritisQ67429351
Mortality among arthriticsQ67757844
Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritisQ67976858
Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamatesQ68970520
The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritisQ69586065
Efficacy of low-dose methotrexate in rheumatoid arthritisQ69884411
Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trialQ69899068
Rheumatoid arthritis and cancer studies based on linking nationwide registries in FinlandQ70055542
Cause of death in rheumatoid arthritisQ71349315
Immunophagocytic properties of retinal pigment epithelium cellsQ71416591
Antimalarial therapy and early retinal changes in patients with rheumatoid arthritisQ72756290
Unusual ocular lesions in a case of systemic lupus erythematosusQ74435603
Ocular abnormalities in patients treated with synthetic antimalarial drugsQ76428819
P433issue2
P921main subjectazathioprineQ18939
rheumatoid arthritisQ187255
methotrexateQ422232
antimalarialQ521616
hepatotoxicityQ1349821
P304page(s)193-206
P577publication date1990-08-01
P1433published inBailliere's clinical rheumatologyQ27710332
P1476titleThe risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis
P478volume4

Reverse relations

Q42548802Azathioprine-induced lymphoma manifesting as fulminant hepatic failurecites workP2860

Search more.